Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Trans-arterial Treatment of Patients With Intra-hepatic Cholangiocarcinoma Not Amenable to Resection (TOMCAT)

NCT06313203 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.

NCT NCT06313203
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06313203 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Trans-arterial Treatment of Patients With Intra-hepatic Cholangiocarcinoma Not Amenable to Resection (TOMCAT)
Lead sponsor
Oslo University Hospital
Phase
Phase 2
Overall status
Recruiting
Start date
February 13, 2024
Completion date
January 31, 2034
Enrollment
39 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapy effect, intrahepatic cholangiocarcinoma